This review provides an update on the current role of endobronchial ultrasound-guided
transbronchial needle aspiration (EBUS-TBNA) and mediastinoscopy (Med) in assessment …

BACKGROUND Surgical resection has been the standard treatment for early stage multiple
primary lung cancer (MPLC). However, a significant proportion of patients with MPLC cannot …

Introduction We determined whether pretreatment immunologic parameters could predict the
outcomes and toxicity in early-stage non–small-cell lung cancer (NSCLC) patients treated …

Background A substantial proportion of patients with clinical stage I non-small cell lung
cancer (NSCLC) have more advanced disease on final pathologic review. We studied …

Abstract Background/Objectives Oligometastatic sarcoma pulmonary metastases (PM's) are
traditionally treated with resection and/or chemotherapy. We hypothesize that stereotactic …

Abstract Stereotactic Body Radiotherapy (SBRT) represents a consolidated treatment option
for patients with medically inoperable early stage non-small cell lung cancer (NSCLC). The …

Purpose To identify the optimal dose parameters predictive for local/lobar control after
stereotactic ablative radiation therapy (SABR) in early-stage non-small cell lung cancer …

Background The optimal treatment of stage I non–small-cell lung carcinoma is subject to
debate. The aim of this study was to compare overall survival and oncologic outcomes of …

Objective Lobectomy is considered optimal therapy for early-stage non–small cell lung
cancer, but sublobar wedge resection and stereotactic body radiation therapy are alternative …

Objectives Our goal was to evaluate stereotactic ablative radiotherapy (SABR) as a salvage
option for isolated recurrence of NSCLC in the lung parenchyma after definitive treatment of …